staphylococcus aureus vaccine
Vaccineexperimental
Clinical trial activity
6 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2015 (NCT02338804)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Staphylococcus aureusImmunity, active
Staphylococcus aureus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- staphylococcus aureus vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02804711 | Phase 1 | Sep 1, 2016 | Chengdu Olymvax Biopharmaceuticals Inc., Government of China, People's Liberation Army of China |
| NCT02820883 | Early Phase 1 (Phase 1) | Jun 1, 2016 | Chengdu Olymvax Biopharmaceuticals Inc., Government of China, People's Liberation Army of China |
| NCT02338700 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2015 | Jinan University |
| NCT02338752 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2015 | Jinan University |
| NCT02338778 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2015 | Jinan University |
| NCT02338804 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2015 | Jinan University |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jinan University | Academic/Hospital | 4 | 4 | 1 | 2015 |
| Chengdu Olymvax Biopharmaceuticals Inc. | For profit | 2 | 0 | 1 | 2016 |
| Government of China | Government | 2 | 2 | 1 | 2016 |
| People's Liberation Army of China | Government | 2 | 0 | 1 | 2016 |
4 organizations
Page 1 / 1